Changes

Jump to navigation Jump to search
13 bytes added ,  15:25, 24 April 2012
Line 61: Line 61:  
*iC3b is inactive in the complement cascade but is a major target for phagocytes
 
*iC3b is inactive in the complement cascade but is a major target for phagocytes
 
**Phagocytes have large numbers of iC3b receptors (complement receptors) which give opsonisation when engaged. </p>
 
**Phagocytes have large numbers of iC3b receptors (complement receptors) which give opsonisation when engaged. </p>
 +
[[Image:Complement Mannose Binding Lectin Pathway.png|thumb|right|250px|'''Mannose Binding Lectin pathway in detail''']]
 
<p>The main effects of alternative complement activation are therefore:
 
<p>The main effects of alternative complement activation are therefore:
 
#To coat bacteria with iC3b
 
#To coat bacteria with iC3b
Line 68: Line 69:  
#*Induce the production of the cytokines (IL-1&beta; and TNF&alpha;) responsible for acute inflammation</p>
 
#*Induce the production of the cytokines (IL-1&beta; and TNF&alpha;) responsible for acute inflammation</p>
   −
===MB-Lectin Pathway===
+
===Mannose Binding-Lectin Pathway===
[[Image:Complement Mannose Binding Lectin Pathway.png|thumb|right|250px|'''Mannose Binding Lectin pathway in detail''']]
   
<p>Lectins are proteins that bind carbohydrates e.g. collectins. They bind carbohydrates that have a terminal mannose residue and are called mannose-binding lectins.
 
<p>Lectins are proteins that bind carbohydrates e.g. collectins. They bind carbohydrates that have a terminal mannose residue and are called mannose-binding lectins.
 
*Secreted by the liver into plasma.  
 
*Secreted by the liver into plasma.  
495

edits

Navigation menu